Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcomes After Conversion to a Belatacept-based Immunosuppression in Kidney Transplant

NCT04733131 is registered in ClinicalTrials.gov with Paris Translational Research Center for Organ Transplantation as lead sponsor.

NCT NCT04733131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04733131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcomes After Conversion to a Belatacept-based Immunosuppression in Kidney Transplant
Lead sponsor
Paris Translational Research Center for Organ Transplantation
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2004
Completion date
December 31, 2021
Enrollment
324 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug effect prolonged, graft loss, immunosuppression, kidney transplant failure and rejection